Renal Cell Carcinoma: Attenuation Values on Unenhanced CT
|
|
- Carmel Farmer
- 5 years ago
- Views:
Transcription
1 Genitourinary Imaging Original Research Pooler et al. Attenuation Values of Unenhanced CT of Renal Cell Carcinoma Genitourinary Imaging Original Research B. Dustin Pooler 1 Perry J. Pickhardt 1 Stacy D. O Connor 1 Richard J. Bruce 1 Sutchin R. Patel 2 Stephen Y. Nakada 2 Pooler BD, Pickhardt PJ, O Connor SD, Bruce RJ, Patel SR, Nakada SY Keywords: attenuation, CT, renal cell carcinoma, renal mass, unenhanced CT DOI: /AJR Received July 14, 2011; accepted after revision October 4, Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI Address correspondence to P. J. Pickhardt (ppickhardt2@uwhealth.org). 2 Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI. AJR 2012; 198: X/12/ American Roentgen Ray Society Renal Cell Carcinoma: Attenuation Values on Unenhanced CT OBJECTIVE. The purpose of this study is to analyze the attenuation values of pathologically proven renal cell carcinomas (RCCs) on unenhanced CT and to determine the range of values wherein malignancy should be considered. MATERIALS AND Methods. A retrospective review was performed of 189 consecutive patients with 193 pathologically proven RCCs 1 cm or larger on unenhanced CT. For each RCC, attenuation values were assessed throughout the tumor by continuous sampling with a mm 2 region of interest (ROI), avoiding foci of calcification and peritumoral volume averaging. The lowest and highest ROI attenuation values per lesion were recorded. Each tumor was categorized as either homogeneous or heterogeneous on the basis of visual inspection with soft-tissue window settings. RESULTS. The 193 malignant tumors ranged in size from 1.1 to 20.1 cm (mean [± SD], 5.1 ± 3.4 cm). Eighteen RCCs (9.3%) were homogeneous in appearance on unenhanced CT. The minimum and maximum ROI attenuation values obtained by sampling throughout each tumor were 27.5 ± 10.4 HU (range, 4 67 HU) and 39.7 ± 10.6 HU (range, HU), respectively. Regional areas of minimum attenuation less than 20 HU and maximum attenuation greater than 70 HU were seen in 24.9% (48/193) and 2.1% (4/193) of RCCs, respectively. However, all 193 RCCs (100%) were predominantly composed of noncalcific regions within HU; 72.5% (140/193) fell entirely within this HU danger zone, including all 18 homogeneous lesions. CONCLUSION. All proven RCCs in this series contained substantial noncalcified regions that measured HU in ROI attenuation on unenhanced CT. Indeterminate renal lesions on unenhanced CT measuring within this HU danger zone warrant further workup, whereas lesions that fall entirely outside this range may be considered benign. T he incidence of renal cell carcinoma (RCC) has increased in the United States over the last few decades [1]. Renal lesions are common incidental findings on CT [2], and, consequently, radiologists are frequently faced with the question of how to manage these incidentalomas [3]. This can be even more vexing for lesions found on unenhanced CT studies, because the internal structure of the lesion can be more difficult to assess without the benefit of IV contrast agent [4]. This issue is particularly relevant because unenhanced CT is being increasingly used for a variety of indications, including diagnosis and monitoring of kidney stones [5, 6] and CT colonography [7]. Previous studies have suggested that an average unenhanced attenuation of greater than 70 HU or less than 20 HU in a homogeneous lesion generally indicates benignity and no further workup is required [8 10]. However, the corollary of how to manage heterogeneous renal lesions or those that extend into the HU range is not as well established. Characteristics suggestive of a benign renal lesion on unenhanced CT have been well studied [8, 11]. However, most studies have focused primarily on benign cystic lesions, with relatively few centered on pathologically proven RCC. Furthermore, the sample sizes of proven RCCs have been relatively small [9, 12]. In studies where larger series of pathologically proven RCCs were examined, the focus has largely been on contrast enhancement and imaging features [13]. The purpose of this study is to specifically analyze the unenhanced CT appearance of a large series of pathologically proven RCCs to determine the range of attenuation values AJR:198, May
2 Pooler et al. TABLE 1: Patient and Lesion Characteristics Characteristic Value Patients (n = 189) Sex Male 123 (65.1) Female 66 (34.9) Age (y), mean ± SD (range) 59.6 ± 12.9 (14 83) Tumors (n = 193) Location Right side 100 (51.8) Left side 92 (47.7) Transplant 1 (0.5) Histologic subtype Clear cell 155 (80.3) Papillary 24 (12.4) Chromophobe 10 (5.2) Sarcomatoid 3 (1.6) Medullary 1 (0.5) Pathologic grade Grade I 44 (22.8) Grade II 76 (39.4) Grade III 26 (13.5) Grade IV 8 (4.1) Not reported 39 (20.2) Note Except where noted otherwise, data are no. (%). wherein malignancy should be reasonably suspected and further workup performed. Materials and Methods This HIPAA-compliant study was performed under an institutional review board approved protocol. The requirement for informed consent was waived because of the retrospective nature of the study. Review of the electronic medical record at our institution from January 1, 2000, through December 31, 2009, identified a total of 556 consecutive patients with a pathologically proven RCC 1 cm or larger. Previous research has shown that incidental renal lesions 1 cm or smaller are clinically unimportant and are generally too small to adequately characterize [14]. Of these 556 cases, 308 were excluded because of the lack of a unenhanced CT series on file, and an additional 59 patients were excluded because of unenhanced studies that did not completely image the tumor or were substantially obscured by artifact. The study cohort was formed by the remaining 189 patients (mean [± SD] age, 59.6 ± 12.9 years; range, years; 123 male and 66 female patients with 193 total proven RCCs) who had a preintervention unenhanced CT scan that completely imaged the tumor without significant artifacts on file within the PACS. The histologic subtype and grade of each tumor was noted from the pathology report in the electronic medical record. Table 1 details the demographic and tumor specifics of this cohort. Clear cell histopathology was the predominant tumor subtype, representing 80.3% of cases. Nearly 40% of the reported histologic tumor grading was classified as grade II. All patients were imaged using a 120-kVp technique at CT allowing meaningful interpatient comparison of attenuation numbers, which are measured in Hounsfield units (HU). All CT scanners were calibrated for attenuation values on a daily basis to ensure measurement consistency and accuracy. The tube current level for the unenhanced series was dependent on the specific protocol and patient body habitus, which affects the SD (noise) of the attenuation measurement but not the mean HU within a measured region of interest (ROI). The unenhanced series were typically reconstructed with 5-mm slice thickness at 3-mm intervals. All CT images were reviewed on standard PACS. After correlation with pathologic and surgical reports to ensure that the correct lesion had been identified, the measurable range of mean attenuation values (in HU) within an ROI (referred to hereafter as ROI attenuation ) was obtained for each lesion by continuously sampling throughout the tumor parenchyma in multiple axial slices with a circular ROI mm 2 in cross-sectional area, appropriately scaled to the size of the lesion. Care was taken to exclude areas of focal calcification and to avoid the extreme periphery of the tumor to minimize volume-averaging effects from surrounding normal tissues. The lowest and highest ROI attenuation values obtained for each lesion were recorded. The ROI attenuation range was calculated by determining the difference between the highest and lowest recorded ROI attenuation values. The maximum linear tumor diameter was measured with electronic calipers in the axial plane. Each tumor was also categorized in a binary fashion as either homogeneous or heterogeneous according to subjective visual inspection; soft-tissue window settings (400 HU window width, centered at 50 HU) were used in all cases to maintain consistency, as well as to best simulate the clinical setting in which these lesions would be encountered. Criteria for defining lesions as heterogeneous included visual identification of any complex internal structures (i.e., septations, mural nodules, calcifications, and visible attenuation differences), whereas lesions identified as homogeneous appeared uniform in composition throughout on visual assessment with soft-tissue windowing. Statistical analysis was performed using publicly available online calculators. p values for continuously measured variables were determined using the Student t test ( ttest1.cfm), p values for categoric variables were determined using the Fisher exact test for contingency tables ( html), and where multiple variables were compared, p values were determined using analysis of variance ( Calculation of correlation coefficients and respective p values were performed using Microsoft Excel. Results The 193 pathology-proven RCCs ranged in maximum transverse cross-sectional diameter from 1.1 to 20.1 cm (mean, 5.1 ± 3.4 cm). On unenhanced CT, 90.7% (175/193) were categorized as heterogeneous, and 9.4% (18/193) were categorized as homogeneous on visual inspection. Internal foci of calcification were noted in 15.5% (30/193) of tumors, all of which were categorized as heterogeneous. The average maximum unenhanced ROI attenuation of all lesions was 39.7 ± 10.6 HU (range, HU), and the average minimum ROI attenuation was 27.5 ± 10.4 HU (range, 4 67 HU). The average attenuation span per lesion (i.e., maximum ROI minus minimum ROI) was 13.0 ± 7.3 HU for heterogeneous tumors and 4.6 ± 2.3 HU for homogeneous tumors (p < 0.001). Minimum ROI attenuation was less than 20 HU in 24.9% (48/193) of tumors, and maximum ROI attenuation was greater than 70 HU in 2.1% (4/193) of tumors. However, all 193 RCCs had ROI attenuation values that crossed into the attenuation zone of HU. Of all tumors, 72.5% (140/193) fell entirely within this HU zone, including all 18 homogeneous lesions. These findings are summarized in Figure 1. Examples of homogeneous and heterogeneous tumors are shown in Figure 2 and Figure 3, respectively. When comparing heterogeneous (n = 175) and homogeneous (n = 18) tumors using the Student t test, there were no statistically significant differences between the two groups in terms of patient age at time of CT (59.6 vs 59.4 years; p = ), average maximum ROI attenuation (40.1 vs 35.7 HU; p = ), or average minimum ROI attenuation (27.1 vs 31.1 HU; p = ). Statistically significant differences were found in average cross-sectional diameter (5.4 vs 2.3 cm; p < ) and average ROI attenuation span (13.0 vs 4.6 HU; p < ). The comparison between heterogeneous and homogeneous tumors is summarized in Table AJR:198, May 2012
3 Attenuation Values of Unenhanced CT of Renal Cell Carcinoma CT Attenuation (HU) Lesions (n = 193) Heterogeneous Homogeneous Fig. 1 Range of unenhanced CT region of interest (ROI) attenuation values for renal cell carcinoma (RCC). Plot showing ROI attenuation span for each of 193 pathologyproven RCCs shows that all tumors have regions that cross into HU danger zone. Most lesions fall entirely within this zone, including all 18 homogeneousappearing tumors (blue diamonds). A C Fig year-old man with renal cell carcinoma (RCC) with homogeneous appearance on unenhanced CT. A C, Unenhanced (A), nephrographic (B), and excretory (C) phase CT images show 2.7-cm homogeneous left renal lesion that measures HU on unenhanced region of interest attenuation measurement. This mildly borderdeforming lesion is most conspicuous on excretory phase image (C). Note also benign cyst extending off lower pole of right kidney, which is less than 20 HU and does not enhance after administration of contrast agent. Indeterminate left renal lesion proved to be chromophobe RCC. B AJR:198, May
4 Pooler et al. Fig year-old man with renal cell carcinoma with heterogeneous appearance on unenhanced CT. A and B, Unenhanced CT images show 8-cm heterogeneous right renal mass that ranges from 18 to 41 HU in region of interest (ROI) attenuation. C and D, Contrast-enhanced CT images at same levels show increased heterogeneity, with large area of low attenuation that corresponds to ROI attenuation measurement under 20 HU. Regardless, majority of tumor crosses into HU danger zone on unenhanced CT. Comparison of histologic subtypes (excluding the single case of medullary RCC) revealed no statistically significant difference in maximum linear cross-sectional diameter (p = 0.37) or average ROI attenuation span (p = 0.68) among clear cell, papillary, chromophobe, and sarcomatoid tumors. Comparison of the histologic subtypes using the two-tailed Fisher exact test revealed no statistically significant differences in the proportion of heterogeneous versus homogeneous lesions among clear cell, papillary, chromophobe, and sarcomatoid tumors (p = 0.64). Additionally, among all lesions there was no statistically significant correlation noted between maximum linear diameter and maximum ROI attenuation (R 2 = 0.062; p = 0.39) or minimum ROI attenuation (R 2 = 0.021; p = 0.77). Comparison of pathologic grades (again excluding the single case of medullary RCC) A C revealed statistically significant differences in maximum linear cross-sectional diameter (grade I = 4.2 cm, grade II = 4.9 cm, grade III = 7.3 cm, and grade IV = 9.9 cm; p < 0.001) and average ROI attenuation span (grade I = 11.4 HU, grade II = 12.2 HU, grade III = 14.9 HU, and grade IV = 19.6 HU; p = 0.02). Additional comparison of pathologic grades revealed no statistically significant difference in the proportion of heterogeneous versus homogeneous lesions (p = 0.57). Discussion Irrespective of heterogeneous or homogeneous visual appearance on unenhanced CT, all proven RCCs in this large series contained noncalcified areas within the tumor that clearly measured HU in ROI attenuation on unenhanced CT, with nearly three-quarters falling entirely within this zone. Therefore, we think that a renal mass with ROI attenuation values that cross into this HU danger zone on unenhanced CT should raise suspicion for possible malignancy and further workup should be considered. To be clear, although 25% of tumors had focal regions less than 20 HU and 2% of tumors had areas greater than 70 HU, all 193 cancers had substantial noncalcified regions that measured HU. As a corollary, none of the pathologically proven RCCs in this large series were noted to have attenuation values that fell completely outside of the HU danger zone, implying that incidental lesions found on unenhanced CT with internal ROI attenuation values entirely outside this zone may confidently be called benign and the patient spared the cost and anxiety of further workup. Specifically, homogeneous lesions consistently measur- B D 1118 AJR:198, May 2012
5 Attenuation Values of Unenhanced CT of Renal Cell Carcinoma TABLE 2: Comparison of Heterogeneous and Homogeneous Tumors Characteristic Heterogeneous (n = 175) Homogeneous (n = 18) p Patient characteristics Sex Male, no. (%) 115 (65.7) 12 (66.6) Female, no. (%) 60 (34.3) 6 (33.3) Age (y) 59.6 ± ± ROI attenuation (HU) Maximum 40.1 ± ± Minimum 27.1 ± ± ROI attenuation span per lesion 13.0 ± ± 2.3 < Lesion diameter (cm) 5.4 ± ± 0.9 < Note Except where noted otherwise, data are mean ± SD. ROI = region of interest. ing less than 20 HU should represent benign cysts (or angiomyolipomas if > 0 HU because of macroscopic fat) and homogeneous lesions measuring greater than 70 HU should represent high-attenuation benign cysts. A recent complementary study evaluating more than 400 patients with incidental renal lesions found on unenhanced CT for screening colonography showed that all lesions outside the HU range were benign, whereas all four proven RCCs were within this danger zone [15]. Not surprisingly, a number of benign lesions also entered the danger zone, with a corresponding positive predictive value for RCC of 10% in this study of asymptomatic adults. Although the HU range is clearly not specific for RCC, it appears that ROI attenuation values entirely outside this range are specific for benignity. Our data add to this previous study by confirming that the HU range is a very sensitive indicator for RCC detection. Together, these two articles provide a useful framework for clinical management. There is surprisingly little information in the existing literature regarding the unenhanced attenuation of pathology-proven RCC. Until recently, this issue had not been of major clinical importance, because most patients undergoing CT evaluation of the abdomen and pelvis generally received IV contrast agents for a wide variety of indications. With the increasing use of unenhanced CT for indications, including urolithiasis [5, 6] and colorectal evaluation [7], as well as in the setting of renal insufficiency or concern for contrast agent reactions, the issue of which renal lesions warrant further workup has become highly relevant in clinical practice. Our results build on the prior evidence, although most data regarding unenhanced attenuation of RCC are buried in studies that focused on contrast enhancement. One small series reported a mean attenuation of 20 HU or higher in 26 of 27 (96.3%) pathology-proven RCCs on unenhanced CT, with a mean attenuation of 18 HU in the remaining lesion [12]. Another small series reported a mean attenuation on unenhanced CT of 31.9 ± 7.0 HU for clear cell RCC (n = 29), 33.5 ± 5.6 HU for papillary RCC (n = 5), and 40.3 ± 3.0 HU for chromophobe RCC (n = 2) [16]. A somewhat larger series focusing on enhancement characteristics of RCC reported mean unenhanced attenuation values of 35 HU (range, HU) for clear cell RCCs (n = 108), 39.5 HU (range, HU) for papillary RCCs (n = 30), and 39 HU (range, HU) for chromophobe RCCs (n = 24) [13]. Another study focusing on enhancement characteristics indicated that the mean unenhanced attenuation of 56 pathologically proven RCCs was HU, depending on the Bosniak class [17]. Finally, a recent study focusing on differentiation of hyperdense renal cysts from RCCs on unenhanced CT reported an average attenuation of HU (range, HU) for 54 RCCs scored by two different readers [9]. In addition to featuring a larger series, our study expands on these previous studies by focusing particularly on the attenuation span of individual lesions and suggests a management strategy for lesions of any density discovered incidentally on unenhanced CT. One potential limitation of these previous studies in characterizing renal lesions on unenhanced CT lies in the use of a single ROI measurement to assess attenuation [9, 12, 13, 16, 17]. Because most of the pathology-proven RCCs in this study were heterogeneous in composition, we think that our method of continuously sampling throughout the tumor parenchyma to determine an attenuation range offers a better characterization of these lesions. Additionally, in these previous studies, the region of tumor sampled on unenhanced CT was usually analogous to the area that appeared to most vigorously enhance on contrast-enhanced CT. Because a large number of our studies had no corresponding contrastenhanced image (e.g., CT colonography and nephrolithiasis protocol), this sampling strategy was not possible. As the volume of these unenhanced-only studies continues to increase in clinical practice, an evidence-based system for triaging incidentally discovered lesions without the benefit of IV contrast agent is becoming increasingly crucial. Malignancy will undoubtedly be a concern for many incidental renal lesions that are found to be heterogeneous in appearance on unenhanced CT. However, incidental lesions that appear homogeneous can present a greater diagnostic challenge, because most incidentalomas found on CT will be benign cysts, leaving the question of when to suspect malignancy in a homogeneous lesion. Prior studies have suggested that homogeneous lesions with attenuation values less than 20 HU and greater than 70 HU can be considered benign and no further workup is required [8 10, 15]. The data from this series are supportive of these conclusions because all 18 of the homogeneous pathologically proven RCCs presented here had attenuation values that fell entirely within the HU danger zone. In the present study, homogeneous RCCs occurred over the same age and sex distributions as their heterogeneous counterparts. They also possessed attenuation values over virtually the same spectrum as their heterogeneous counterparts, with similar values for average maximum and minimum ROI attenuation (Table 2). As expected, homogeneous lesions were found to have a narrower range of attenuation values, which correlates well with their subjective uniform appearance on CT. They were also found to be significantly smaller in diameter than the heterogeneous lesions, which would be logically expected, because complex internal structures would be more difficult to identify in smaller lesions, and larger tumor size likely facilitates heterogeneity. There was no significant difference in ROI attenuation range among the various histologic subtypes, illustrating the difficulty of attempting to predict histologic subtype on the basis of unenhanced CT findings. With AJR:198, May
6 Pooler et al. the addition of IV contrast agent, the degree of tumor enhancement can predict histologic subtype to some degree, with papillary tumors having a lesser degree of enhancement [18]. In contrast, there were significant differences seen among pathologic grades in both average maximum linear diameter and average midrange ROI attenuation. Overall, higher grade tumors were found to be larger and, on average, denser than their lower-grade counterparts, while also having a larger average ROI attenuation span. These results support earlier research showing that higher grade RCCs, on average, grow faster than lower grade RCCs and, consequently, are generally larger at presentation [19]. The limitations of this study are mostly related to its single-center retrospective nature, raising possible issues with regard to generalization of results and selection bias. The daily quality assurance testing of our CT scanners ensures more consistent ROI attenuation values. In addition, all scans were performed using a 120-kVp technique, which further improves reproducibility. Scanning at different energy levels will affect CT numbers to some degree, which may be an issue with the dual-energy technique. One caveat involves the direct application of our ROI attenuation data to other CT scanner manufacturers, because vendor-specific differences are known to exist [20, 21]. Ideally, future research would prospectively identify and follow a large number of incidental renal lesions found on unenhanced CT and triaged according to the HU danger zone to better assess patient outcomes and determine the performance statistics of this method. In summary, our results show that all proven RCCs in this series contained substantial noncalcified regions that measured HU in ROI attenuation on unenhanced CT. Given that renal lesions completely outside this range have proven to be benign in previous work, we conclude that indeterminate renal lesions on unenhanced CT that contain areas of ROI attenuation that cross over into this HU danger zone will generally warrant further workup. References 1. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: Barrett TW, Schierling M, Zhou C, et al. Prevalence of incidental findings in trauma patients detected by computed tomography imaging. Am J Emerg Med 2009; 27: Berland LL, Silverman SG, Gore RM, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010; 7: Curry NS, Cochran ST, Bissada NK. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR 2000; 175: Bariol SV, Tolley DA. What is the best imaging for stone management? BJU Int 2005; 95: Catalano O, Nunziata A, Sandomenico F, Siani A. Acute flank pain: comparison of unenhanced helical CT and ultrasonography in detecting causes other than ureterolithiasis. Emerg Radiol 2002; 9: Pickhardt PJ, Hanson ME, Vanness DJ, et al. Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 2008; 249: Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology 2005; 66: Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology 2007; 243: Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology 2008; 249: Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR 1988; 151: Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, Adams DF. Small ( 3 cm) renal masses: correlation of spinal CT features and pathological findings. AJR 1994; 163: Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244: Willatt J, Francis IR. Imaging and management of the incidentally discovered renal mass. Cancer Imaging 2009;9(Spec No A):S30 S O Connor SD, Pickhardt PJ, Kim DH, Oliva MR, Silverman SG. Incidental renal masses at unenhanced CT: prevalence and analysis of features for guiding management. AJR 2011; 197: Jinzaki M, Tanimoto A, Mukai M, et al. Doublephase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24: Song C, Min GE, Song K, et al. Differential diagnosis of complex cystic renal mass using multiphase computerized tomography. J Urol 2009; 181: Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR 2002; 178: Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197: Sande EPS, Martinsen ACT, Hole EO, Olerud HM. Interphantom and interscanner variations for Hounsfield units: establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 2010; 55: Birnbaum BA, Hindman N, Lee J, Babb JS. Multidetector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 2007; 242: AJR:198, May 2012
Pseudoenhancement of Renal Cysts: Influence of Lesion Size, Lesion Location, Slice Thickness, and Number of MDCT Detectors
Genitourinary Imaging Original Research Tappouni et al. MDCT of Renal Cysts Genitourinary Imaging Original Research Rafel Tappouni 1 Jennifer Kissane 2 Nabeel Sarwani 1 Erik B. Lehman 1 Tappouni R, Kissane
More informationThe Incidental Renal lesion
The Incidental Renal lesion BACKGROUND Increase in abdominal CT/US in last 15 years Resulted in detection of many (small) renal lesions 50% > 50yrs has at least 1 lesion majority simple cysts Renal lesions
More informationAnalysis of Changes in Attenuation of Proven Renal Cysts on Different Scanning Phases of Triphasic MDCT
Eugene P. Chung 1 Brian R. Herts 1,2 Grant Linnell 1 Andrew C. Novick 2 Nancy Obuchowski 1,3 Deirdre M. Coll 1,4 Mark E. Baker 1 Received June 24, 2003; accepted after revision August 28, 2003. Presented
More informationChromophobe Renal Cell Carcinoma: Multiphase MDCT Enhancement Patterns and Morphologic Features
Genitourinary Imaging Original Research Raman et al. Enhancement Patterns and Morphologic Features of Chromophobe Renal Cell Carcinoma Genitourinary Imaging Original Research Siva P. Raman 1 Pamela T.
More informationINTERDISCIPLINARY DISCUSSIONS IN LOCALISED RCC DIAGNOSIS AND SURGICAL STRATEGIES FOR ATYPICAL RENAL CYSTIC LESIONS. Maria Cova
INTERDISCIPLINARY DISCUSSIONS IN LOCALISED RCC DIAGNOSIS AND SURGICAL STRATEGIES FOR ATYPICAL RENAL CYSTIC LESIONS Maria Cova Radiology Department University of Trieste (IT) Eleventh European International
More informationSmall (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT
Genitourinary Imaging Original Research Takahashi et al. CT of Small Renal Masses Genitourinary Imaging Original Research Naoki Takahashi 1 Shuai Leng 1 Kazuhiro Kitajima 1,2 Daniel Gomez-Cardona 1,3 Prabin
More informationDo Incidental Hyperechoic Renal Lesions Measuring Up to 1 cm Warrant Further Imaging? Outcomes of 161 Lesions
Genitourinary Imaging Original Research Genitourinary Imaging Original Research Ankur M. Doshi 1 Abimbola Ayoola Andrew B. Rosenkrantz Doshi AM, Ayoola A, Rosenkrantz AB Keywords: angiomyolipoma, hyperechoic
More informationCME Article Clinics in diagnostic imaging (135)
Medical Education Singapore Med J 2011; 52(5) : 384 CME Article Clinics in diagnostic imaging (135) Pojchamarnwiputh S, Muttarak M, Sriplakich S H 1a 1b 1c 1d Fig. 1 (a) Axial unenhanced; (b & c) delayed
More informationEnhancement Characteristics of Papillary Renal Neoplasms Revealed on Triphasic Helical CT of the Kidneys
Brian R. Herts 1 Deirdre M. Coll 1,2 Andrew C. Novick 3 Nancy Obuchowski 1,4 Grant Linnell 1 Susan L. Wirth 1 Mark E. Baker 1 Received June 29, 2001; accepted after revision August 23, 2001. 1 Department
More informationHistogram Analysis of Small Solid Renal Masses: Differentiating Minimal Fat Angiomyolipoma From Renal Cell Carcinoma
Genitourinary Imaging Original Research Chaudhry et al. Histogram Analysis of Small Solid Renal Masses Genitourinary Imaging Original Research Humaira S. Chaudhry 1,2 Matthew S. Davenport 1,3 Christopher
More informationThe role of Bosniak classification in malignant tumor diagnosis: A single institution experience
Original Article - Urological Oncology http://dx.doi.org/10.4111/icu.2016.57.2.100 pissn 2466-0493 eissn 2466-054X The role of Bosniak classification in malignant tumor diagnosis: A single institution
More informationRenal Mass Biopsy: Needed Now More than Ever
Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationSTANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE
STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE COLLABORATIVE Pamela Johnson 1, Darcy Wolfman 2, Upma Rawal 3,
More informationQualitative and Quantitative MDCT Features for Differentiating Clear Cell Renal Cell Carcinoma From Other Solid Renal Cortical Masses
Genitourinary Imaging Original Research Lee-Felker et al. MDCT Differentiation of Clear Cell RCC Genitourinary Imaging Original Research Stephanie A. Lee-Felker 1 Ely R. Felker 1 Nelly Tan 1 Daniel J.
More informationManagement of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee
ORIGINAL ARTICLE Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee Brian R. Herts, MD a, Stuart G. Silverman, MD b, Nicole M. Hindman, MD c, Robert G.
More information11/1/2014. Radiologic incidentalomas Ordering pitfalls Newer technology and applications
Bilal Tahir, MD Gitasree Borthakur, MD Indiana University School of Medicine Department of Radiology & Imaging Sciences October 31, 2014 ACP 2014 Dr. V. Aaron Nuclear (vaaron@iupui.edu) Dr. S. Westphal
More informationAre There Useful CT Features to Differentiate Renal Cell Carcinoma From Lipid-Poor Renal Angiomyolipoma?
Genitourinary Imaging Original Research Yang et al. Imaging Differentiation of Benign and Malignant Renal Tumors Genitourinary Imaging Original Research Ching-Wei Yang 1,2 Shu-Huei Shen 3,4 Yen-Hwa Chang
More informationTHYROID NODULES: THE ROLE OF ULTRASOUND
THYROID NODULES: THE ROLE OF ULTRASOUND NOVEMBER 2017 DR. DEAN DURANT DEFINITION Thyroid nodule: Focal area within the thyroid gland with echogenicity different from surrounding parenchyma. THYROID NODULES
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More informationIs Ultrasound Useful for Further Evaluation of Homogeneously Hyperattenuating Renal Lesions Detected on CT?
Genitourinary Imaging Original Research Genitourinary Imaging Original Research Mahadevaswamy Siddaiah 1 Satheesh Krishna Matthew D. F. McInnes Jeffrey S. Quon Wael M. Shabana Demetri Papadatos Nicola
More information(2/3 PRCC!) (2/3 PRCC!)
Approach to the Incidental Solid Renal Mass Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationGemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis
GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor
More informationCharacterization of Small Solid Renal Lesions: Can Benign and Malignant Tumors Be Differentiated With CT?
Genitourinary Imaging Original Research Millet et al. CT of Small Solid Renal Lesions Genitourinary Imaging Original Research Ingrid Millet 1 Fernanda Curros Doyon 1 Denis Hoa 1 Rodolphe Thuret 2 Samuel
More informationRenal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others
The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of
More informationImaging characterization of renal clear cell carcinoma
Imaging characterization of renal clear cell carcinoma Poster No.: C-0327 Congress: ECR 2011 Type: Educational Exhibit Authors: S. Ballester 1, A. Gaser 2, M. Dotta 1, M. F. CAPPA 1, F. Hammar 1 ; 1 2
More informationL. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD
Computed Tomography Urography (CTU) for Evaluation of Asymptomatic microscopic hematuria. Is intravenous contrast administration warranted for all patients? A retrospective evaluation utilizing ACR s Appropriateness
More informationSmall renal mass: differential diagnosis on image
Small renal mass: differential diagnosis on image Poster No.: R-0166 Congress: RANZCR-AOCR 2012 Type: Educational Exhibit Authors: H. Lee, K. S. Lee, M. J. Kim; Anyang/KR Keywords: Cysts, Cancer, Staging,
More informationDual-Energy CT: The Technological Approaches
Dual-Energy CT: The Technological Approaches Dushyant Sahani, M.D Director of CT Associate Professor of Radiology Massachusetts General Hospital Harvard Medical School Email-dsahani@partners.org Disclosure
More informationMeasure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
More informationRADIOLOGICAL CLASSIFICATION OF RENAL ANGIOMYOLIPOMAS BASED ON 127 TUMORS
Clinical Urology International raz J Urol Official Journal of the razilian Society of Urology IMGING OF RENL NGIOMYOLIPOMS Vol. 29 (3): 208-216, May - June, 2003 RDIOLOGICL CLSSIFICTION OF RENL NGIOMYOLIPOMS
More informationMDCT Findings of Renal Cell Carcinoma Associated With Xp11.2 Translocation and TFE3 Gene Fusion and Papillary Renal Cell Carcinoma
Genitourinary Imaging Original Research Woo et al. MDCT in Renal Cell Carcinoma Genitourinary Imaging Original Research Sungmin Woo 1 Sang Youn Kim 1 Myoung Seok Lee 1 Kyung Chul Moon 2 See Hyung Kim 3
More informationREVIEW. Distinguishing benign from malignant adrenal masses
Cancer Imaging (2003) 3, 102 110 DOI: 10.1102/1470-7330.2003.0006 CI REVIEW Distinguishing benign from malignant adrenal masses Isaac R Francis Professor of Radiology, Department of Radiology, University
More informationIncidental findings: A retrospective analysis of management
Incidental findings: A retrospective analysis of management Authors and disclosures Authors: Steven Boe, Dana Boe, Jeffrey Kaye, Anu Bansal, Marc Glickstein Disclosures: None Purpose Determine if appropriate
More informationNonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings
Chin J Radiol 2002; 27: 239-243 239 Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings CHAO-HSUAN YEN 1 JEN-HWEY CHIANG 1 JEN-I HUANG 3 CHENG-SHI SU 2 YI-YOU CHIOU 1 CHENG-YEN
More informationTo Shield or Not to Shield? Lincoln L. Berland, M.D.
To Shield or Not to Shield? Lincoln L. Berland, M.D. Disclosures Consultant to: Nuance, Inc. Page 2 Breast Radiation on CT Use of chest CT has increased in women vulnerable to cancer induction by radiation.
More informationESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain
ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain OUR APPROACH Incidental adrenal nodule/mass Isaac R Francis, M.B;B.S University of Michigan, Ann Arbor, Michigan Disclosures None (in memory) M Korobkin,
More informationAcute renal colic Radiological investigation in patients with renal colic
Acute renal colic Radiological investigation in patients with renal colic Mikael Hellström Professor Department of Radiology Sahlgrenska University Hospital Göteborg University 0.9-1.8/1.000 inhabitants
More informationGenitourinary Imaging Original Research
Genitourinary Imaging Original Research Masch et al. Genitourinary Imaging Original Research William R. Masch 1 Richard H. Cohan 1,2 James H. Ellis 1,2 Jonathan R. Dillman 1,3 Jonathan M. Rubin 1,2 Matthew
More informationDoses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use?
Doses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use? Eva Godske Friberg * Norwegian Radiation Protection Authority, P.O. Box, Østerås, Norway Abstract.
More informationRenal masses - the role of diagnostic imaging
Renal masses - the role of diagnostic imaging Poster No.: C-2471 Congress: ECR 2015 Type: Educational Exhibit Authors: V. Rai#; Bjelovar/HR Keywords: Cysts, Cancer, Structured reporting, Ultrasound, MR,
More informationCystic Renal Cell Carcinomas: Do They Grow, Metastasize, or Recur?
Genitourinary Imaging Original Research Jhaveri et al. Growth Patterns of Cystic Renal Cell Carcinomas Genitourinary Imaging Original Research Kartik Jhaveri 1 Priya Gupta 1 Azadeh Elmi 2 Lior Flor 1 Hadas
More informationAlternate and Incidental Diagnoses on Noncontrast- Enhanced Spiral Computed Tomography for Acute Flank Pain
Endourology and Stone Disease Alternate and Incidental Diagnoses on Noncontrast- Enhanced Spiral Computed Tomography for Acute Flank Pain M Hammad Ather, Kulsoom Faizullah, Ilyas Achakzai, Rizwan Siwani,
More informationImaging findings of papillary renal cell carcinoma
Imaging findings of papillary renal cell carcinoma Poster No.: C-0286 Congress: ECR 2015 Type: Educational Exhibit Authors: J. Praia, R. Dias, C. Macedo, J. Albuquerque, M. Certo ; 1 1 2 2 1 2 2 Barreiro/PT,
More informationSonographically Identified Echogenic Renal Masses Up to 1 cm in Size Are So Rarely Malignant They Can Be Safely Ignored
ORIGINAL RESEARCH Sonographically Identified Echogenic Renal Masses Up to 1 cm in Size Are So Rarely Malignant They Can Be Safely Ignored Malak Itani, MD, Amit Pandya, MBBS, Ronald O. Bude, MD Received
More informationLow-Dose CT: Clinical Studies & the Radiologist Perspective
Low-Dose CT: Clinical Studies & the Radiologist Perspective RD-ASiR RD-MBIR SD-FBP RD=0.35 msv (80% dose reduction) Perry J. Pickhardt, MD UW School of Medicine & Public Health Low-Dose CT: Clinical Overview
More informationSarcomatoid renal cell carcinoma: A case report and literature review
Sarcomatoid renal cell carcinoma: A case report and literature review Michael Reiter 1*, Ryan Schwope 1, Arthur Clarkson 2 1. Department of Radiology, Brooke Army Medical Center, San Antonio USA 2. Department
More informationHow To Approach Renal Masses? - Differential Diagnosis On Image
How To Approach Renal Masses? - Differential Diagnosis On Image Poster No.: C-1646 Congress: ECR 2015 Type: Educational Exhibit Authors: A. E. A. G. Costa, A. Gomes, A. Duarte, I. Távora; Lisbon/PT Keywords:
More informationHyperechoic renal masses
Hyperechoic renal masses Jean-Yves Meuwly, MD Department of Diagnostic and Interventional Radiology, University Hospital Lausanne, Switzerland Department of Diagnostic and Interventional Radiology Renal
More informationGenitourinary Imaging Original Research
Genitourinary Imaging Original Research Patel et al. CT of Synchronous Renal Masses Genitourinary Imaging Original Research Uday Patel 1 Navin Ramachandran James Halls Aneeta Parthipun Catherine Slide
More information4,3,2,1...How Many Phases are Needed? Balancing Diagnostic Efficacy and Radiation Modulation for MDCT Imaging of Renal Cell Carcinoma
4,3,2,1...How Many Phases are Needed? Balancing Diagnostic Efficacy and Radiation Modulation for MDCT Imaging of Renal Cell Carcinoma Jeremy Hackworth, MD, MS Steven P Rowe, MD, PhD Satomi Kawamoto, MD
More informationRenal Masses With Equivocal Enhancement at CT: Characterization With Contrast- Enhanced Ultrasound
Genitourinary Imaging Original Research Bertolotto et al. Use of Contrast-Enhanced Ultrasound to Characterize Renal Masses Genitourinary Imaging Original Research Michele Bertolotto 1 Calogero Cicero 2
More informationLow-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2
Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening
More informationAcknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols
Personalization of Pediatric Imaging in Terms of Needed Indication-Based Quality Per Dose Acknowledgments Duke University Medical Center Ehsan Samei, PhD Donald Frush, MD Xiang Li PhD DABR Cleveland Clinic
More informationCharacterization of Renal Cell Carcinoma Using Agent Detection Imaging: Comparison with Gray-Scale US
Characterization of Renal Cell Carcinoma Using Agent Detection Imaging: Comparison with Gray-Scale US Byung Kwan Park, MD 1, 2 Seung Hyup Kim, MD 1 Hyuck Jae Choi, MD 1 Index terms: Contrast media Ultrasound
More informationDual Energy CT: a new tool in evaluation of the urinary tract stones composition in clinical practice - initial study
Dual Energy CT: a new tool in evaluation of the urinary tract stones composition in clinical practice - initial study Poster No.: C-2279 Congress: ECR 2013 Type: Scientific Exhibit Authors: M. Guzi#ski,
More informationThe diagnostic criteria of multilocular renal cysts
Case Report 772 Multilocular Renal Cysts with Renal Cell Carcinoma: Report of Four Cases Chia-Hsi Chen, MD; Cheng-Keng Chuang, MD, PhD; Chun-Te Wu, MD; Kwai-Fong Ng 1, MD; Shuen-Kuei Liao 2, PhD According
More informationMultidetector Computed Tomography Evaluation of Subtypes of Renal Cell Carcinoma
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/390 Multidetector Computed Tomography Evaluation of Subtypes of Renal Cell Carcinoma A Rohini 1, Vidya Bhargavi 2,
More informationRadiation Dose Reduction: Should You Use a Bismuth Breast Shield?
Radiation Dose Reduction: Should You Use a Bismuth Breast Shield? Lincoln L. Berland, M.D., F.A.C.R. Michael V. Yester, Ph.D. University of Alabama at Birmingham Breast Radiation on CT Use of chest CT
More informationMRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS
MRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS Ambesh Deshar *, Gyanendra KC and Zhang Lopsang *Department of Medical Imaging and Nuclear Medicine, First
More informationThe Frequency and Significance of Small (15 mm) Hepatic Lesions Detected by CT
535 Elizabeth C. Jones1 Judith L. Chezmar Rendon C. Nelson Michael E. Bernardino Received July 22, 1991 ; accepted after revision October 16, 1991. Presented atthe annual meeting ofthe American Aoentgen
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 46/Sep 22, 2014 Page 11296
CT SPECTRUM OF GIANT RETROPERITONEAL LIPOSARCOMAS WITH HISTOPATHOLOGICAL CORRELATION Shashikumar M. R 1, Rajendra Kumar N. L 2, C. P. Nanjaraj 3, Nishanth R. K 4, Vishwanath Joshi 5 HOW TO CITE THIS ARTICLE:
More informationCase-based discussion:
Case-based discussion: Pailin Kongmebhol, M.D. Department of Radiology Faculty of Medicine Chiang Mai University There are many guidelines for managing thyroid nodules Two important guidelines: 2015 American
More informationMANAGEMENT RECOMMENDATIONS
1 MANAGEMENT RECOMMENDATIONS 1. Adrenal masses!!!!!!! page 2 2. Liver Masses!!!!!!! page 3 3. Obstetric US Soft Markers for Aneuploidy!! pages 4-6 4. Ovarian and Adnexal Cysts!!!!! pages 7-10 5. Pancreatic
More informationComputed Tomography of Normal Adrenal Glands in Indian Population
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. V January. (2018), PP 26-30 www.iosrjournals.org Computed Tomography of Normal Adrenal
More informationDaniela Faivovich K., MS VII Universidad de Chile Gillian Lieberman, MD Harvard Medical School
Daniela Faivovich K., MS VII Universidad de Chile Gillian Lieberman, MD Harvard Medical School May 21st, 2010 56 year old male patient History of hypertension, hyperlipidemia and insulin-resistance 2009:
More informationNon-calculus causes of renal colic on CT KUB
Non-calculus causes of renal colic on CT KUB Poster No.: C-1341 Congress: ECR 2010 Type: Scientific Exhibit Topic: Genitourinary Authors: A. Afaq, E. L. Leen; London/UK Keywords: renal colic, CT KUB, appendicitis
More informationCT Colonography Reporting and Data System (C-RADS): Benchmark Values From a Clinical Screening Program
Gastrointestinal Imaging Original Research Pooler et al. Benchmark C-RADS Values From a Clinical Screening Program Gastrointestinal Imaging Original Research B. Dustin Pooler 1 David H. Kim Vu P. Lam Elizabeth
More informationBiases affecting tumor uptake measurements in FDG-PET
Biases affecting tumor uptake measurements in FDG-PET M. Soret, C. Riddell, S. Hapdey, and I. Buvat Abstract-- The influence of tumor diameter, tumor-tobackground activity ratio, attenuation, spatial resolution,
More informationReviewer's report. Version:1Date:31 January Reviewer:IOANNIS LEOTSAKOS. Reviewer's report:
Reviewer's report Title:A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria
More informationGuidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening
Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening 1. Introduction In January 2005, the Committee for Preparation of Clinical Practice Guidelines for the Management
More informationReview Article Radiologic Evaluation of Small Renal Masses (I): Pretreatment Management
Hindawi Publishing Corporation Advances in Urology Volume 2008, Article ID 415848, 16 pages doi:10.1155/2008/415848 Review Article Radiologic Evaluation of Small Renal Masses (I): Pretreatment Management
More informationFused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience
Original Article Fused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience Shun-Yu Gao, Xiao-Peng Zhang, Yong Cui, Ying-Shi
More informationImaging of Kidney Cancer
119 Imaging of Kidney Cancer RADIOLOGIC CLINICS OF NORTH AMERICA Radiol Clin N Am 45 (2007) 119 147 Jingbo Zhang, MD*, Robert A. Lefkowitz, MD, Ariadne Bach, MD - Detection and diagnosis - CT scan Solid
More informationComparison of Radiological Criteria (RECIST - MASS - SACT -Choi) in Antiangiogenic Therapy of Renal Cell Carcinoma
Universal Journal of Public Health 4(5): 239-243, 2016 DOI: 10.13189/ujph.2016.040503 http://www.hrpub.org Comparison of Radiological Criteria (RECIST - MASS - SACT -Choi) in Antiangiogenic Therapy of
More informationContrast Enhanced Ultrasound of Parenchymal Masses in Children
Contrast Enhanced Ultrasound of Parenchymal Masses in Children Sue C Kaste, DO On behalf of Beth McCarville, MD St. Jude Children s Research Hospital Memphis, TN Overview Share St. Jude experience with
More informationESTABLISHING DRLs in PEDIATRIC CT. Keith Strauss, MSc, FAAPM, FACR Cincinnati Children s Hospital University of Cincinnati College of Medicine
ESTABLISHING DRLs in PEDIATRIC CT Keith Strauss, MSc, FAAPM, FACR Cincinnati Children s Hospital University of Cincinnati College of Medicine CT Dose Indices CTDI INTRODUCTION CTDI 100, CTDI w, CTDI vol
More informationDetection of Renal Stones on Portal Venous Phase CT: Comparison of Thin Axial and Coronal Maximum- Intensity-Projection Images
Genitourinary Imaging Original Research Corwin et al. Detection of Renal Stones on Portal Venous Phase CT Genitourinary Imaging Original Research Michael T. Corwin 1 Justin S. Lee 1 Ghaneh Fananapazir
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationBilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report
Case Study TheScientificWorldJOURNAL (2008) 8, 145 148 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.29 Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report C. Blick, N. Ravindranath,
More informationImaging Decisions Start Here SM
Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan
More informationRadiological Appearance of Renal Leiomyoma: two cases report and review of the literature
J Radiol Sci 2012; 37: 139-143 Radiological Appearance of Renal Leiomyoma: two cases report and review of the literature Wei-Ni Liao 1 Chi-Kuan Chen 2 Fei-Shih Yang 1,3 Department of Radiology 1, Department
More informationNewcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital
Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians
More informationEthan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2, Patrick Smith, M.D. 2, and Larry S. Matthews, M.D. 2
Skeletal Radiol (1986) 15:27-31 Skeletal Radiology Computed tomography and plain radiography in experimental fracture healing Ethan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2,
More informationImplementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL
Implementation of the 2012 ACR CT QC Manual in a Community Hospital Setting BRUCE E. HASSELQUIST, PH.D., DABR, DABSNM ASPIRUS WAUSAU HOSPITAL Conflict of Interest Disclaimer Employee of Aspirus Wausau
More informationHealth Care Policy and Quality Original Research
Health Care Policy and Quality Original Research Health Care Policy and Quality Original Research JOURNAL CLUB Cleo K. Maehara 1,2 Stuart G. Silverman 1,2,3 Ronilda Lacson 1,2 Ramin Khorasani 1,2,3 Maehara
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Renal and adrenal tumours Faculty of Clinical Radiology www.rcr.ac.uk Contents Renal cell carcinoma 3 Clinical
More informationHEPATO-BILIARY IMAGING
HEPATO-BILIARY IMAGING BY MAMDOUH MAHFOUZ MD PROF.OF RADIOLOGY CAIRO UNIVERSITY mamdouh.m5@gmail.com www.ssregypt.com CT ABDOMEN Indications Patient preparation Patient position Scanogram Fasting 4-6 hours
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationCT & MRI of Benign Liver Neoplasms Srinivasa R Prasad
CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad No financial disclosures Acknowledgements Many thanks to Drs. Heiken, Narra & Menias (MIR) Dr. Sahani (MGH) for sharing images Benign Liver Tumors:
More informationBaker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah MD*, Nizar Saaydah MD* ABSTRACT
Renal Cell Carcinoma Clinical Presentation and Histopathological Findings: A Retrospective Analysis of a Jordanian Population at King Hussein Medical Center Baker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More information354 Korean J Radiol 9(4), August 2008
Review of Failed CT Phantom Image Evaluations in 2005 and 2006 by the CT Accreditation Program of the Korean Institute for Accreditation of Medical Image Hye Jung Park, MD 1 Seung Eun Jung, MD 1, 2 Young
More informationX-Ray & CT Physics / Clinical CT
Computed Tomography-Basic Principles and Good Practice X-Ray & CT Physics / Clinical CT INSTRUCTORS: Dane Franklin, MBA, RT (R) (CT) Office hours will be Tuesdays from 5pm to 6pm CLASSROOM: TIME: REQUIRED
More informationCT NUMBER ACCURACY ANALYSIS FOR RADIOTHERAPY TREATMENT PLANNING IMAGING
CT NUMBER ACCURACY ANALYSIS FOR RADIOTHERAPY TREATMENT PLANNING IMAGING Julian Liu a, Keisha Robinson a, DhanaJayan Kothandan a and Joshua Luis b (a) Cancer Centre London (b) University College London
More informationChapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology
Chapter 6 Interscan variability of semiautomated volume measurements in intraparenchymal pulmonary nodules using multidetector-row computed tomography: Influence of inspirational level, nodule size and
More informationACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts Grace H. Elta, MD, FACG 1, Brintha K. Enestvedt, MD, MBA 2, Bryan G. Sauer, MD, MSc, FACG (GRADE Methodologist) 3 and Anne Marie Lennon,
More informationAsk EuroSafe Imaging. Tips & Tricks. CT Working Group
Ask EuroSafe Imaging Tips & Tricks CT Working Group The use of bi-phase injection protocols to reduce the number of acquisition phases and radiation dose Alban Gervaise (Medical Imaging Department, HIA
More informationDownloaded from by on 11/26/17 from IP address Copyright ARRS. For personal use only; all rights reserved
Ronald J. Zagoria 1 Elaine G. Khatod Michael Y. M. Chen Received July 14, 2000; accepted after revision October 24, 2000. 1 ll authors: Department of Radiology, Wake Forest University School of Medicine,
More informationBayesian Classifier for Predicting Malignant Renal Cysts on MDCT: Early Clinical Experience
Genitourinary Imaging Original Research Lee et al. Bayesian Classifier for Diagnosing Renal Cysts on MDCT Genitourinary Imaging Original Research Bayesian Classifier for Predicting Malignant Renal Cysts
More information